drugset / Trial / NCT05748938
A Study of RD14-01 in Patients With Advanced Solid Tumors
Phase 1/2
Unknown
12 enrolled
920th Hospital of Joint Logistics Support Force of People's Liberation Army of China
NaSingle-groupOpen-labelTreatment
Summary
This study will evaluate the safety and tolerability of RD14-01, a ROR1-targeted CAR T-cell therapy, in patients with ROR1+ advanced solid tumors.
Timeline
- Start
- 2023-02-08
- Primary completion
- 2024-08-08
- Completion
- 2025-02-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | RD14-01 | Cell therapy | — | Intravenous |